Drug Database
Back to search

Germany· DE-A57-2a73acdeff784f0a

Cabazitaxel Mylan

A cabazitaxel product containing cabazitaxel, registered in Germany by Mylan Germany Gmbh. The same ATC class is registered in 15 of our 19 countries.

ATC L01CD04

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCabazitaxel MylanATCL01CD04REGISTER NO.DE-A57-2a73acdeff784f…PACKS LISTED0CHECKEDAugust 5, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cabazitaxelAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cabazitaxel is registered in 15 of 19 countries.

Countries holding a registration under ATC L01CD04 (cabazitaxel), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search cabazitaxel products by name

Cabazitaxel · ATC L01CD04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cabazitaxel costs, country by country.

Normalised to the WHO defined daily dose (2.14 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cabazitaxel · price per daily dose (2.14 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$115.73
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Cabazitaxel
Manufacturer
Mylan Germany Gmbh
Country
Germany (DE)
ATC code
L01CD04
ATC class
Cabazitaxel
Defined daily dose
2.14 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
August 5, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

300 interactions on record for cabazitaxel.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cabazitaxel against other medicinesHow interaction checks work

Cabazitaxel · interactions on record

300 records

  • 29 severe
  • 269 moderate
  • 2 minor

Most severe, free to view

  • CladribineL01BB04severe
  • ClotrimazoleA01AB18moderate
  • AprepitantA04AD12moderate
  • MiconazoleA07AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cabazitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cabazitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cabazitaxel Ever Pharma 10 Mg/Ml Konzentrat Zur Herstellung Einer Infusionslösung, Cabazitaxel Fresenius Kabi
  • Belgium · Cabazitaxel Eg (Eurogenerics), Cabazitaxel Eugia
  • Bulgaria · Елебер, Кабазитаксел Ever Pharma 10 Mg/Ml Концентрат За Инфузионен Разтвор
  • Czechia · Cabazitaxel Agmed, Cabazitaxel Ever Pharma
  • Denmark · Cabazitaxel "medical Valley", Cabazitaxel "sandoz"
  • Estonia · Cabazitaxel Fresenius Kabi, Cabazitaxel Sandoz
  • Spain · Cabazitaxel Aurovit, Cabazitaxel Dr. Reddys
  • Finland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • France · Cabazitaxel Eg Labo, Cabazitaxel Ever Pharma
  • United Kingdom (Northern Ireland) · Cabazitaxel Dr. Reddy's Laboratories (Uk), Cabazitaxel Fresenius Kabi
  • Greece · Cabazitaxel /Fresenius Kabi, Cabazitaxel Ariti
  • Croatia · Eleber, Kabazitaksel Ever Pharma 10 Mg/Ml Koncentrat Za Otopinu Za Infuziju
  • Hungary · Cabazitaxel, Cabazitaxel Ever Pharma
  • Ireland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Iceland · Cabazitaxel Accord, Cabazitaxel Stada
  • Italy · Cabazitaxel Dr. Reddy’s, Cabazitaxel Ever Pharma
  • Liechtenstein · Cabazitaxel Accord, Jevtana
  • Lithuania · Cabazitaxel Fresenius Kabi, Cabazitaxel Sandoz
  • Luxembourg · Cabazitaxel Eg, Cabazitaxel Eugia
  • Latvia · Cabazitaxel Fresenius Kabi, Cabazitaxel Stada
  • Malta · Cabazitaxel Fresenius Kabi
  • Netherlands · Cabazitaxel Cf, Cabazitaxel Eugia
  • Norway · Cabazitaxel Accord, Cabazitaxel Ever Pharma
  • Poland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Portugal · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Romania · Cabazitaxel Aqvida, Cabazitaxel Ever Pharma
  • Sweden · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Slovenia · Cabazitaxel Ever Pharma, Eleber
  • Slovakia · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aede3d92-d643-4091-abe2-3fea7ef78bd1
GET /v1/drugs/aede3d92-d643-4091-abe2-3fea7ef78bd1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Cabazitaxel",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about cabazitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console